{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:19:04Z","timestamp":1792887544128,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Kyowa Kirin International","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00198-020-05548-0","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T17:03:03Z","timestamp":1595610183000},"page":"7-22","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Burden of disease associated with X-linked hypophosphataemia in adults: a systematic literature review"],"prefix":"10.1007","volume":"32","author":[{"given":"L.","family":"Seefried","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Keen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Harvengt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,24]]},"reference":[{"key":"5548_CR1","unstructured":"Orphanet (2019) X-linked hypophosphatemia. https:\/\/www.orpha.net\/consor\/cgi-bin\/OC_Exp.php?Expert=89936. Accessed August 2019"},{"issue":"7","key":"5548_CR2","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/jbmr.340","volume":"26","author":"TO Carpenter","year":"2011","unstructured":"Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL (2011) A clinician's guide to X-linked hypophosphatemia. J Bone Miner Res 26(7):1381\u20131388","journal-title":"J Bone Miner Res"},{"issue":"1","key":"5548_CR3","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/EC-13-0103","volume":"3","author":"A Linglart","year":"2014","unstructured":"Linglart A, Biosse-Duplan M, Briot K, Chaussain C, Esterle L, Guillaume-Czitrom S, Kamenicky P, Nevoux J, Prie D, Rothenbuhler A, Wicart P, Harvengt P (2014) Therapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocr Connect 3(1):R13\u2013R30","journal-title":"Endocr Connect"},{"issue":"1","key":"5548_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13023-019-1014-8","volume":"14","author":"SS Beck-Nielsen","year":"2019","unstructured":"Beck-Nielsen SS, Mughal Z, Haffner D, Nilsson O, Levtchenko E, Ariceta G, de Lucas CC, Schnabel D, Jandhyala R, M\u00e4kitie O (2019) FGF23 and its role in X-linked hypophosphatemia-related morbidity. Orphanet J Rare Dis 14(1):58","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"5548_CR5","first-page":"91","volume":"13","author":"AG McWhorter","year":"1991","unstructured":"McWhorter AG, Seale NS (1991) Prevalence of dental abscess in a population of children with vitamin D-resistant rickets. Pediatr Dent 13(2):91\u201396","journal-title":"Pediatr Dent"},{"issue":"7","key":"5548_CR6","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1210\/js.2018-00365","volume":"3","author":"A Skrinar","year":"2019","unstructured":"Skrinar A, Dvorak-Ewell M, Evins A, Macica C, Linglart A, Imel EA, Theodore-Oklota C, San Martin J (2019) The lifelong impact of X-linked hypophosphatemia: results from a burden of disease survey. J Endocr Soc 3(7):1321\u20131334","journal-title":"J Endocr Soc"},{"key":"5548_CR7","unstructured":"EMA (2019) Crysvita: summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/crysvita-epar-product-information_en.pdf. Accessed August 2019"},{"issue":"7","key":"5548_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","volume":"15","author":"D Haffner","year":"2019","unstructured":"Haffner D, Emma F, Eastwood DM, Duplan MB, Bacchetta J, Schnabel D, Wicart P, Bockenhauer D, Santos F, Levtchenko E, Harvengt P, Kirchhoff M, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenicky P, Rejnmark L, Linglart A (2019) Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol 15(7):435\u2013455","journal-title":"Nat Rev Nephrol"},{"key":"5548_CR9","unstructured":"FDA (2018) Crysvita: prescribing information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/761068s004lbl.pdf. Accessed May 2020"},{"issue":"3","key":"5548_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1530\/EJE-15-0661","volume":"174","author":"H Che","year":"2016","unstructured":"Che H, Roux C, Etcheto A, Rothenbuhler A, Kamenicky P, Linglart A, Briot K (2016) Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms. Eur J Endocrinol 174(3):325\u2013333","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"5548_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-016-0538-4","volume":"11","author":"L Forestier-Zhang","year":"2016","unstructured":"Forestier-Zhang L, Watts L, Turner A, Teare H, Kaye J, Barrett J, Cooper C, Eastell R, Wordsworth P, Javaid MK, Pinedo-Villanueva R (2016) Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia. Orphanet J Rare Dis 11(1):1\u20139","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"5548_CR12","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/jbmr.3475","volume":"33","author":"K Insogna","year":"2018","unstructured":"Insogna K, Briot K, Imel E, Kamenicky P, Ruppe M, Portale A, Weber T, Pitukcheewanont P, Cheong H, Jan de Beur S, Imanishi Y, Ito N, Lachmann R, Tanaka H, Perwad F, Zhang L, Chen C, Theodore-Oklota C, Mealiffe M, San Martin J, Carpenter T (2018) A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis. J Bone Miner Res 33(8):1383\u20131393","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"5548_CR13","first-page":"S457","volume":"30","author":"A Skrinar","year":"2015","unstructured":"Skrinar A, Marshall A, San Martin J, Dvorak-Ewell M, MaCica C (2015) Pain resulting from unresolved skeletal disease has a significant impact on the daily function of adults with X-linked hypophosphatemia (XLH). J Bone Miner Res 30(Suppl 1):S457","journal-title":"J Bone Miner Res"},{"key":"5548_CR14","unstructured":"Skrinar A, Ayla M, Javier San M, Melita D-E (2015) X-linked hypophosphatemia (XLH) impairs skeletal health outcomes and physical function in affected adults. Endocrine Society Annual Meeting, San Diego, CA, USA PP29-3"},{"issue":"7","key":"5548_CR15","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097","journal-title":"PLoS Med"},{"key":"5548_CR16","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P (2019) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed May 2020"},{"issue":"3","key":"5548_CR17","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1067\/mpd.2003.119","volume":"142","author":"C Chaussain-Miller","year":"2003","unstructured":"Chaussain-Miller C, Sinding C, Wolikow M, Lasfargues JJ, Godeau G, Garabedian M (2003) Dental abnormalities in patients with familial hypophosphatemic vitamin D-resistant rickets: prevention by early treatment with 1-hydroxyvitamin D. J Pediatr 142(3):324\u2013331","journal-title":"J Pediatr"},{"issue":"3","key":"5548_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00223-017-0363-3","volume":"102","author":"VV Shanbhogue","year":"2018","unstructured":"Shanbhogue VV, Hansen S, Jorgensen NR, Beck-Nielsen SS (2018) Impact of conventional medical therapy on bone mineral density and bone turnover in adult patients with X-linked hypophosphatemia: a 6-year prospective cohort study. Calcif Tissue Int 102(3):321\u2013328","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"5548_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1365-2842.2011.02250.x","volume":"39","author":"MG Andersen","year":"2012","unstructured":"Andersen MG, Beck-Nielsen SS, Haubek D, Hintze H, Gjorup H, Poulsen S (2012) Periapical and endodontic status of permanent teeth in patients with hypophosphatemic rickets. J Oral Rehabil 39(2):144\u2013150","journal-title":"J Oral Rehabil"},{"issue":"10","key":"5548_CR20","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1210\/JC.2015-2199","volume":"100","author":"J Connor","year":"2015","unstructured":"Connor J, Olear EA, Insogna KL, Katz L, Baker S, Kaur R, Simpson CA, Sterpka J, Dubrow R, Zhang JH, Carpenter TO (2015) Conventional therapy in adults with X-linked hypophosphatemia: effects on enthesopathy and dental disease. J Clin Endocrinol Metab 100(10):3625\u20133632","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"5548_CR21","doi-asserted-by":"publisher","first-page":"E1492","DOI":"10.1210\/jc.2012-1336","volume":"97","author":"LN Veilleux","year":"2012","unstructured":"Veilleux LN, Cheung M, Ben Amor M, Rauch F (2012) Abnormalities in muscle density and muscle function in hypophosphatemic rickets. J Clin Endocrinol Metab 97(8):E1492\u2013E1498","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"5548_CR22","doi-asserted-by":"publisher","first-page":"E990","DOI":"10.1210\/jc.2012-4146","volume":"98","author":"LN Veilleux","year":"2013","unstructured":"Veilleux LN, Cheung MS, Glorieux FH, Rauch F (2013) The muscle-bone relationship in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 98(5):E990\u2013E995","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"5548_CR23","first-page":"33","volume":"45","author":"M Berndt","year":"1996","unstructured":"Berndt M, Ehrich JHH, Lazovic D, Zimmermann J, Hillmann G, Kayser C, Prokop M, Schirg E, Siegert B, Wolff G, Brodehl J (1996) Clinical course of hypophosphatemic rickets in 23 adults. Clin Nephrol 45(1):33\u201341","journal-title":"Clin Nephrol"},{"issue":"9","key":"5548_CR24","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1093\/oxfordjournals.ndt.a027716","volume":"11","author":"JHH Ehrich","year":"1996","unstructured":"Ehrich JHH, Filler G (1996) Hypophosphataemic rickets in children and adults. Nephrol Dial Transplant 11(9):1918\u20131919","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"5548_CR25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000045518","volume":"83","author":"D Haffner","year":"1999","unstructured":"Haffner D, Weinfurth A, Manz F, Schmidt H, Bremer HJ, Mehls O, Scharer K (1999) Long-term outcome of paediatric patients with hereditary tubular disorders. Nephron 83(3):250\u2013260","journal-title":"Nephron"},{"issue":"13","key":"5548_CR26","doi-asserted-by":"publisher","first-page":"E792","DOI":"10.1097\/BRS.0b013e31824a3dc8","volume":"37","author":"SH Lee","year":"2012","unstructured":"Lee SH, Agashe MV, Suh SW, Yoon YC, Song SH, Yang JH, Lee H, Song HR (2012) Paravertebral ligament ossification in vitamin D-resistant rickets: incidence, clinical significance, and genetic evaluation. Spine 37(13):E792\u2013E796","journal-title":"Spine"},{"issue":"3","key":"5548_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1507\/endocrj.EJ16-0199","volume":"64","author":"Y Nakamura","year":"2017","unstructured":"Nakamura Y, Takagi M, Takeda R, Miyai K, Hasegawa Y (2017) Hypertension is a characteristic complication of X-linked hypophosphatemia. Endocr J 64(3):283\u2013289","journal-title":"Endocr J"},{"issue":"8","key":"5548_CR28","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1210\/jcem.82.8.4181","volume":"82","author":"R Nehgme","year":"1997","unstructured":"Nehgme R, Fahey JT, Smith C, Carpenter TO (1997) Cardiovascular abnormalities in patients with X-linked hypophosphatemia. J Clin Endocrinol Metab 82(8):2450\u20132454","journal-title":"J Clin Endocrinol Metab"},{"issue":"8668","key":"5548_CR29","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/S0140-6736(89)91559-6","volume":"2","author":"GB Stickler","year":"1989","unstructured":"Stickler GB, Morgenstern BZ (1989) Hypophosphataemic rickets: final height and clinical symptoms in adults. Lancet 2(8668):902\u2013905","journal-title":"Lancet"},{"key":"5548_CR30","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bone.2019.01.021","volume":"121","author":"C Zhang","year":"2019","unstructured":"Zhang C, Zhao Z, Sun Y, Xu L, JiaJue R, Cui L, Pang Q, Jiang Y, Li M, Wang O, He X, He S, Nie M, Xing X, Meng X, Zhou X, Yan L, Kaplan JM, Insogna KL, Xia W (2019) Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia. Bone 121:212\u2013220","journal-title":"Bone"},{"issue":"4","key":"5548_CR31","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/0022034516677528","volume":"96","author":"M Biosse Duplan","year":"2017","unstructured":"Biosse Duplan M, Coyac BR, Bardet C, Zadikian C, Rothenbuhler A, Kamenicky P, Briot K, Linglart A, Chaussain C (2017) Phosphate and vitamin D prevent periodontitis in X-linked hypophosphatemia. J Dent Res 96(4):388\u2013395","journal-title":"J Dent Res"},{"issue":"2","key":"5548_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00223-010-9373-0","volume":"87","author":"SS Beck-Nielsen","year":"2010","unstructured":"Beck-Nielsen SS, Brusgaard K, Rasmussen LM, Brixen K, Brock-Jacobsen B, Poulsen MR, Vestergaard P, Ralston SH, Albagha OM, Poulsen S, Haubek D, Gjorup H, Hintze H, Andersen MG, Heickendorff L, Hjelmborg J, Gram J (2010) Phenotype presentation of hypophosphatemic rickets in adults. Calcif Tissue Int 87(2):108\u2013119","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"5548_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0169-6009(08)80127-4","volume":"24","author":"MJ Econs","year":"1994","unstructured":"Econs MJ, Samsa GP, Monger M, Drezner MK, Feussner JR (1994) X-linked hypophosphatemic rickets: a disease often unknown to affected patients. Bone Miner 24(1):17\u201324","journal-title":"Bone Miner"},{"issue":"5","key":"5548_CR34","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s10545-018-0147-6","volume":"41","author":"D Chesher","year":"2018","unstructured":"Chesher D, Oddy M, Darbar U, Sayal P, Casey A, Ryan A, Sechi A, Simister C, Waters A, Wedatilake Y, Lachmann RH, Murphy E (2018) Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations. J Inherit Metab Dis 41(5):865\u2013876","journal-title":"J Inherit Metab Dis"},{"issue":"10","key":"5548_CR35","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1056\/NEJM196909042811001","volume":"281","author":"SL McNair","year":"1969","unstructured":"McNair SL, Stickler GB (1969) Growth in familial hypophosphatemic vitamin-D-resistant rickets. N Engl J Med 281(10):512\u2013516","journal-title":"N Engl J Med"},{"issue":"6","key":"5548_CR36","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/00005792-198911000-00002","volume":"68","author":"IR Reid","year":"1989","unstructured":"Reid IR, Hardy DC, Murphy WA, Teitelbaum SL, Bergfeld MA, Whyte MP (1989) X-linked hypophosphatemia: a clinical, biochemical and histopathologic assessment of morbidity in adults. Medicine 68(6):336\u2013352","journal-title":"Medicine"},{"issue":"6","key":"5548_CR37","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3346\/jkms.2007.22.6.981","volume":"22","author":"HR Song","year":"2007","unstructured":"Song HR, Park JW, Cho DY, Jae HY, Yoon HR, Jung SC (2007) PHEX gene mutations and genotype\u2013phenotype analysis of Korean patients with hypophosphatemic rickets. J Korean Med Sci 22(6):981\u2013986","journal-title":"J Korean Med Sci"},{"issue":"3","key":"5548_CR38","first-page":"879","volume":"75","author":"W Sullivan","year":"1992","unstructured":"Sullivan W, Carpenter T, Glorieux F, Travers R, Insogna K (1992) A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 75(3):879\u2013885","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"5548_CR39","doi-asserted-by":"publisher","first-page":"230","DOI":"10.7326\/0003-4819-100-2-230","volume":"100","author":"M Davies","year":"1984","unstructured":"Davies M, Kane R, Valentine J (1984) Impaired hearing in X-linked hypophosphataemic (vitamin-D-resistant) osteomalacia. Ann Intern Med 100(2):230\u2013232","journal-title":"Ann Intern Med"},{"issue":"9","key":"5548_CR40","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1507\/endocrj.EJ15-0275","volume":"62","author":"I Endo","year":"2015","unstructured":"Endo I, Fukumoto S, Ozono K, Namba N, Inoue D, Okazaki R, Yamauchi M, Sugimoto T, Minagawa M, Michigami T, Nagai M, Matsumoto T (2015) Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment. Endocr J 62(9):811\u2013816","journal-title":"Endocr J"},{"issue":"8","key":"5548_CR41","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jval.2018.01.013","volume":"21","author":"C Theodore-Oklota","year":"2018","unstructured":"Theodore-Oklota C, Bonner N, Spencer H, Arbuckle R, Chen CY, Skrinar A (2018) Qualitative research to explore the patient experience of X-linked hypophosphatemia and evaluate the suitability of the BPI-SF and WOMAC as clinical trial end points. Value Health 21(8):973\u2013983","journal-title":"Value Health"},{"key":"5548_CR42","doi-asserted-by":"crossref","unstructured":"Wiemann S, Frenzel Baudisch N, Jordan RA, Kleinheinz J, Hanisch M (2018) Oral symptoms and oral health-related quality of life in people with rare diseases in Germany: a cross-sectional study. Int J Environ Res Public Health 15(7)","DOI":"10.3390\/ijerph15071493"},{"issue":"1","key":"5548_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1515\/hsz-2014-0187","volume":"396","author":"L Yuan","year":"2015","unstructured":"Yuan L, Wu S, Xu H, Xiao J, Yang Z, Xia H, Liu A, Hu P, Lu A, Chen Y, Xu F, Deng H (2015) Identification of a novel PHEX mutation in a Chinese family with X-linked hypophosphatemic rickets using exome sequencing. Biol Chem 396(1):27\u201333","journal-title":"Biol Chem"},{"issue":"1","key":"5548_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0026-0495(76)90157-8","volume":"25","author":"JE Harrison","year":"1976","unstructured":"Harrison JE, Cumming WA, Fornasier V, Fraser D, Kooh SW, McNeill KG (1976) Increased bone mineral content in young adults with familial hypophosphatemic vitamin D refractory rickets. Metabolism 25(1):33\u201340","journal-title":"Metabolism"},{"issue":"Suppl 1","key":"5548_CR45","first-page":"S14","volume":"2","author":"M Javaid","year":"2018","unstructured":"Javaid M, Delmestri A, Shaw N, Prieto-Alhambra D, Cooper C, Pinedo-Villanueva R (2018) X-linked hypophosphatemia: burden of disease using United Kingdom primary care data. JBMR Plus 2(Suppl 1):S14\u2013S15","journal-title":"JBMR Plus"},{"key":"5548_CR46","doi-asserted-by":"crossref","unstructured":"Che H, Roux C, Etcheto A, Rothenbuhler A, Kamenicky P, Linglart A, Briot K (2015) Quality of life of adults with X-linked hypophosphatemic rickets. European Congress of rheumatology, Rome, Italy THU0551","DOI":"10.1136\/annrheumdis-2015-eular.1565"},{"issue":"SUPPL. 10","key":"5548_CR47","first-page":"S107","volume":"66","author":"K Briot","year":"2014","unstructured":"Briot K, Che H, Etcheto A, Rothenbuhler A, Kamenicky P, Linglart A, Roux C (2014) Quality of life assessment of adult patients with X-linked hypophosphatemia. Arthritis Rheumatol 66(SUPPL. 10):S107\u2013S108","journal-title":"Arthritis Rheumatol"},{"key":"5548_CR48","unstructured":"Portale AA, Mealiffe M, San Martin J, Carpenter T, Insogna K, Imel E, Kamenicky P, Imanishi Y, Ito N, Perwad F, Zhang L, Theodore-Oklota C (2018) Burosumab improves phosphorus metabolism and fracture healing in adults with X-linked hypophosphatemia (XLH). Kidney Week, San Diego, CA, USA TH-OR023"},{"issue":"Suppl 1","key":"5548_CR49","first-page":"S385","volume":"28","author":"RM Javier","year":"2013","unstructured":"Javier RM, Briot K, Cohen-Solal M, Cortet B, Eloy C, Laroche M, Lafforgue P, De Vernejoul MC (2013) X-linked hypophosphatemia in adults and rheumatological manifestations: cross-sectional survey of the bone section of the French Society of Rheumatology sfr-os. J Bone Miner Res 28(Suppl 1):S385","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"5548_CR50","first-page":"S393","volume":"31","author":"M Ruppe","year":"2016","unstructured":"Ruppe M, Peacock M, Weber T, Portale A, Insogna K, Imel E, Luca D, Skrinar A, Mealiffe M, Martin JS, Carpenter T (2016) Clinical and radiographic characteristics of adult X-linked hypophosphatemia (XLH) in a cohort of patients treated with KRN23, an antibody to FGF23. J Bone Miner Res 31(Suppl 1):S393","journal-title":"J Bone Miner Res"},{"issue":"Suppl 2","key":"5548_CR51","first-page":"1046","volume":"77","author":"A Salcion-Picaud","year":"2018","unstructured":"Salcion-Picaud A, Lassalle L, Merzoug V, Usardi A, Rothenbuhler A, Kamenicky P, Roux C, Linglart A, Briot K (2018) High prevalence of enthesopathies in patients with X-linked hypophosphatemia. Ann Rheum Dis 77(Suppl 2):1046\u20131047","journal-title":"Ann Rheum Dis"},{"key":"5548_CR52","unstructured":"Salcion-Picaud A, Rothenbuhler A, Etcheto A, Molto A, Briot K, Linglart A (2018) Clinical and biological parameters associated to the severity of X-linked hypophosphatemia in children. European Society for Paediatric Endocrinology Annual Meeting, Athens, Greece P2-P041"},{"issue":"5","key":"5548_CR53","doi-asserted-by":"publisher","first-page":"A5","DOI":"10.1053\/S0272-6386(16)00649-1","volume":"67","author":"M Merzkani","year":"2016","unstructured":"Merzkani M, Bloom J, Bhaskaran M, Ali S (2016) X linked hypophosphatemic syndrome in a patient undergoing for renal transplant. Am J Kidney Dis 67(5):A5","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"5548_CR54","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/jbmr.3544","volume":"33","author":"M Collins","year":"2018","unstructured":"Collins M (2018) Burosumab: at long last, an effective treatment for FGF23-associated hypophosphatemia. J Bone Miner Res 33(8):1381\u20131382","journal-title":"J Bone Miner Res"},{"issue":"Suppl 3","key":"5548_CR55","doi-asserted-by":"publisher","first-page":"S466","DOI":"10.1016\/j.jval.2018.09.2746","volume":"21","author":"A Doess","year":"2018","unstructured":"Doess A, May M, Feig C, Keller I, Maessen D (2018) Real world evidence of hereditary hypophosphatemia in Germany \u2013 analysis of German SHI claims data for pediatric patients. Value Health 21(Suppl 3):S466","journal-title":"Value Health"},{"key":"5548_CR56","doi-asserted-by":"crossref","unstructured":"Lopez L, Ha D, Targovnik J, Shah B (2016) Looking beyond osteoporosis: diagnosing X-linked hypophosphatemic rickets in a 60-year old female. American Association of Clinical Endocrinologists Annual Meeting, Orlando, FL, USA 619","DOI":"10.1016\/S1530-891X(20)45096-7"},{"key":"5548_CR57","unstructured":"Maija M, Ingvars R (2015) X-linked hypophosphatemic rickets case report from Latvia. Endocrine Society Annual Meeting, San Diego, CA, USA FRI-217"},{"issue":"Suppl 1","key":"5548_CR58","first-page":"S570","volume":"29","author":"R Oheim","year":"2018","unstructured":"Oheim R (2018) Realigning our thinking: XLH, a lifelong disease. Osteoporos Int 29(Suppl 1):S570","journal-title":"Osteoporos Int"},{"issue":"Suppl 1","key":"5548_CR59","first-page":"S287","volume":"31","author":"B Ramirez","year":"2016","unstructured":"Ramirez B, Cook F, Mumm S, Gottesman G, Madson K, Whyte M (2016) Severe hypophosphatemia in adulthood associated with PHEX 3'-UTR mutation c.*231A>G near the polyadenylation signal. J Bone Miner Res 31(Suppl 1):S287","journal-title":"J Bone Miner Res"},{"key":"5548_CR60","doi-asserted-by":"crossref","unstructured":"Watts L, Wordsworth P (2015) Chiari malformation, syringomyelia and bulbar palsy in X-linked hypophosphataemia. BMJ Case Rep bcr2015211961","DOI":"10.1136\/bcr-2015-211961"},{"issue":"4","key":"5548_CR61","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10067-010-1607-z","volume":"30","author":"S Arthur","year":"2011","unstructured":"Arthur S, Chopra A (2011) Familial hypophosphatemia: an unusual presentation with low back ache, heel pain, and a limp in a young man, and literature review. Clin Rheumatol 30(4):585\u2013589","journal-title":"Clin Rheumatol"},{"key":"5548_CR62","unstructured":"Cheng A, Pelley EM (2016) Tertiary hyperparathyroidism caused by prolonged therapy of X-linked hypophosphatemic rickets. Endocr Rev 37(Suppl 1)"},{"issue":"Suppl 13","key":"5548_CR63","first-page":"S534","volume":"179","author":"RK Crowley","year":"2010","unstructured":"Crowley RK, Morrin M, Kilbane M, McKenna MJ (2010) Tertiary hyperparathyroidism associated with treatment of X-linked hypophosphataemia: paradoxical response to cinacalcet. Ir J Med Sci 179(Suppl 13):S534","journal-title":"Ir J Med Sci"},{"key":"5548_CR64","unstructured":"Gupta S, Kilbane M, Vanderkamp S, McKenna MJ (2012) Osteosclerosis in congenital hypophosphatemic bone disorders. Endocr Rev 33"},{"issue":"SUPPL. 1","key":"5548_CR65","first-page":"380","volume":"80","author":"K Kawano","year":"2013","unstructured":"Kawano K, Yoshii K, Horiuchi K, Osawa M (2013) Cinacalcet has a limited effect in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: a case report. Horm Res Paediatr 80(SUPPL. 1):380\u2013381","journal-title":"Horm Res Paediatr"},{"key":"5548_CR66","unstructured":"Mitta S, Shibli-Rahhal A (2012) Cinacalcet use in X-linked hypophosphatemic rickets complicated by tertiary hyperparathyroidism and hypercalcemia. Endocr Rev 33(Suppl 1)"},{"issue":"1","key":"5548_CR67","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.4158\/EP12184.CR","volume":"19","author":"GE Sun","year":"2013","unstructured":"Sun GE, Suer O, Carpenter TO, Tan CD, Li-Ng M (2013) Heart failure in hypophosphatemic rickets: complications from high-dose phosphate therapy. Endocr Pract 19(1):e8\u2013e11","journal-title":"Endocr Pract"},{"issue":"3","key":"5548_CR68","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1046\/j.1442-200x.2000.01210.x","volume":"42","author":"N Thomas","year":"2000","unstructured":"Thomas N, Burnet R (2000) Hyperparathyroidism and cervical canal stenosis in twins with hypophosphatemic rickets. Pediatr Int 42(3):310\u2013312","journal-title":"Pediatr Int"},{"issue":"3","key":"5548_CR69","first-page":"266","volume":"11","author":"S Tournis","year":"2011","unstructured":"Tournis S, Georgoulas T, Zafeiris C, Papalexis C, Petraki K, Lyritis GP (2011) Tertiary hyperparathyroidism in a patient with X-linked hypophosphatemic rickets. J Musculoskelet Neuronal Interact 11(3):266\u2013269","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"4","key":"5548_CR70","first-page":"257","volume":"1","author":"A Vanacker","year":"2008","unstructured":"Vanacker A, Segaert M, Verbanck J, Van Dorpe J, Poppe B, Maes B (2008) Slow progression of chronic renal failure in a woman of short stature and leg deformities: what is the link? NDT Plus 1(4):257\u2013261","journal-title":"NDT Plus"},{"issue":"3","key":"5548_CR71","doi-asserted-by":"publisher","first-page":"274","DOI":"10.14310\/horm.2002.1277","volume":"9","author":"MP Yavropoulou","year":"2010","unstructured":"Yavropoulou MP, Kotsa K, Gotzamani Psarrakou A, Papazisi A, Tranga T, Ventis S, Yovos JG (2010) Cinacalcet in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review. Hormones 9(3):274\u2013278","journal-title":"Hormones"},{"issue":"Suppl 1","key":"5548_CR72","first-page":"S280","volume":"31","author":"L Forestier-Zhang","year":"2016","unstructured":"Forestier-Zhang L, Watts L, Turner A, Teare H, Barrett J, Wordsworth P, Kaye J, Javaid MK, Pinedo-Villanueva R (2016) Using the RUDY study platform to capture quality of life of adults with rare diseases of the bone. J Bone Miner Res 31(Suppl 1):S280","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"5548_CR73","first-page":"S277","volume":"31","author":"EJ Parisi","year":"2016","unstructured":"Parisi EJ, Feinn R, Ferraro S, Frey M, Garbalosa JC, Gonzalez R, Grgurich T, Muchemi F, Steigbigel K, Tommasini SM, Macica CM (2016) Significant impairments in joint mobility and range of function in adult patients with XLH. J Bone Miner Res 31(Suppl 1):S277","journal-title":"J Bone Miner Res"},{"key":"5548_CR74","unstructured":"Pinedo-Villanueva R, Turner A, Barrett J, Cooper C, Javaid K (2017) Quality of life in adults with X-linked hypophosphataemia (XLH): preservation of emotional well-being despite significant limitations in physical domains. Osteoporos Int 28 Suppl 1:491"},{"issue":"Suppl 1","key":"5548_CR75","first-page":"80","volume":"82","author":"M Ruppe","year":"2014","unstructured":"Ruppe M, Zhang X, Imel E, Weber T, Klausner M, Ito T, Vergeire M, Humphrey J, Glorieux F, Portale A, Insogna K, Peacock M, Carpenter T (2014) Assessment of quality of life data after 4 monthly S.C. doses of a human monoclonal anti-fibroblast growth factor 23 antibody (KRN23) in adults with X-linked hypophosphatemia. Horm Res Paediatr 82(Suppl 1):80\u201381","journal-title":"Horm Res Paediatr"},{"key":"5548_CR76","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.bonr.2016.05.004","volume":"5","author":"MD Ruppe","year":"2016","unstructured":"Ruppe MD, Zhang X, Imel EA, Weber TJ, Klausner MA, Ito T, Vergeire M, Humphrey JS, Glorieux FH, Portale AA, Insogna K, Peacock M, Carpenter TO (2016) Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia. Bone Rep 5:158\u2013162","journal-title":"Bone Rep"},{"key":"5548_CR77","unstructured":"Ruppe MD, Zhang X, Imel EA, Weber TJ, Klausner M, Ito T, Vergeire M, Humphrey J, Glorieux FH, Portale AA, Insogna K, Peacock M, Carpenter TO (2014) Effect of four monthly doses of a human monoclonal anti-FGF23 (fibroblast growth factor 23) antibody (KRN23) on quality of life in X-linked hypophosphatemia (XLH). Endocr Rev 35(Suppl 1)"},{"issue":"11","key":"5548_CR78","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1002\/ajmg.a.36721","volume":"164A","author":"T Pekkarinen","year":"2014","unstructured":"Pekkarinen T, Lorenz-Depiereux B, Lohman M, Makitie O (2014) Unusually severe hypophosphatemic rickets caused by a novel and complex re-arrangement of the PHEX gene. Am J Med Genet A 164A(11):2931\u20132937","journal-title":"Am J Med Genet A"},{"issue":"4","key":"5548_CR79","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2106\/00004623-196850040-00010","volume":"50","author":"S Yoshikawa","year":"1968","unstructured":"Yoshikawa S, Shiba M, Suzuki A (1968) Spinal-cord compression in untreated adult cases of vitamin-D resistant rickets. J Bone Joint Surg Am 50(4):743\u2013752","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"5548_CR80","doi-asserted-by":"publisher","first-page":"451","DOI":"10.4103\/0028-3886.141261","volume":"62","author":"F Xie","year":"2014","unstructured":"Xie F, Cen ZD, Chen LL, Luo W (2014) Cervical spinal cord compression caused by X-linked hypophosphatemic rickets with a novel PHEX mutation. Neurol India 62(4):451\u2013453","journal-title":"Neurol India"},{"issue":"Suppl 1","key":"5548_CR81","first-page":"S197","volume":"9","author":"J Do","year":"2017","unstructured":"Do J, Kiser TS (2017) Inpatient rehabilitation for thoracic myelopathy caused by X-linked hypophosphatemia, a form of congenital rickets, after surgical decompression and fusion: a case report. PM R 9(Suppl 1):S197","journal-title":"PM R"},{"key":"5548_CR82","doi-asserted-by":"publisher","first-page":"139","DOI":"10.11607\/prd.1429","volume":"33","author":"B Friberg","year":"2013","unstructured":"Friberg B (2013) Br\u00e5nemark system implants and rare disorders: a report of six cases. Int J Periodontics Restorative Dent 33:139\u2013148","journal-title":"Int J Periodontics Restorative Dent"},{"key":"5548_CR83","unstructured":"Skrinar A, Marshall A, San Martin J, Dvorak-Ewell M (2015) X-linked hypophosphatemia (XLH) impairs skeletal health outcomes and physical function in affected adults [poster PP29\u20133]. Presented at the Endocrine Society Annual Meeting ENDO, 3\u20135 March 2015, San Diego, CA, USA"},{"key":"5548_CR84","unstructured":"XLH Network, Inc. (2019) Voice of the patient report. https:\/\/xlhnetwork.org\/application\/files\/9415\/7323\/0655\/VOP_and_Transcripts.pdf. Accessed Jan 2020"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05548-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-020-05548-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05548-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T10:05:21Z","timestamp":1650535521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-020-05548-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,24]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["5548"],"URL":"https:\/\/doi.org\/10.1007\/s00198-020-05548-0","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,24]]},"assertion":[{"value":"3 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"As this was secondary research, no ethics approval or patient consent was required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Lothar Seefried.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"P. Harvengt is a member of RVRH-XLH (a member of the International XLH Alliance), which has received funding from Kyowa Kirin for the organization of educational events, and has provided unpaid consulting services to Kyowa Kirin. P. Harvengt is employed by GSK. This publication was prepared by P. Harvengt in his personal capacity. M. Smyth is a former employee of Kyowa Kirin. R. Keen has received honorarium and consultancy fees from Kyowa Kirin. L. Seefried has received honoraria for lectures and advice from Kyowa Kirin.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}